COMPARISON OF METHODS TO IDENTIFY Neisseria meningitidis IN ASYMPTOMATIC CARRIERS
AUTOR(ES)
RIZEK, Camila F., LUIZ, André Machado, ASSIS, Gracilene Ramos de, COSTA, Silvia Figueiredo, LEVIN, Anna Sara, LOPES, Marta Heloisa
FONTE
Rev. Inst. Med. trop. S. Paulo
DATA DE PUBLICAÇÃO
22/09/2016
RESUMO
SUMMARY Neisseria meningitidis is a cause of several life-threatening diseases and can be a normal commensal in the upper respiratory tract of healthy carriers. The carrier rate is not well established especially because there is no standard method for the isolation of N. meningitidis. Therefore, the aim of this study was to compare identification methods for the carrier state. Two swabs were collected from 190 volunteers: one was cultured and the other had DNA extracted directly from the sample. The Polymerase Chain Reaction (PCR) was performed to determine species and serogroups and compared the results between the methods. PCR for species determination used two pairs of primers and when there was only one amplicon, it was sequenced. The culture technique was positive in 23 (12.1%) subjects while the direct extraction method was positive in 132 (69.5%), p < 0.001. Among the 135 subjects with positive N. meningitides tests, 88 (65.2%) were serogroup C; 3 (2.2%) serogroup B; 5 (3.7%) were positive for both serogroup B and C, and 39 (28.9%) did not belong to any of the tested serogroups. In this study, PCR from DNA extracted directly from swabs identified more N. meningitidis asymptomatic carriers than the culture technique.
Documentos Relacionados
- Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers.
- Antibiotic Susceptibility Patterns of Neisseria meningitidis Isolates from Patients and Asymptomatic Carriers
- Molecular subtyping of Neisseria meningitidis serogroup B: comparison of five methods.
- Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population.
- Comparison of passive hemagglutination, bactericidal activity, and radioimmunological methods in measuring antibody responses to Neisseria meningitidis group A capsular polysaccharide vaccine.